Recursion Pharmaceuticals RXRX, a TechBio company that decodes biology and chemistry to industrialize drug discovery, is expected to report fourth-quarter 2025 results soon. The Zacks Consensus ...

Salt Lake City, Utah, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced that on February 6, ...

Recursion Pharmaceuticals Inc. stock reached a new 52-week low, closing at $3.53, just pennies away from its absolute 52-week bottom of $3.54. This milestone marks a significant downturn for the ...

The largest-ever communications satellite of its kind took a major step toward operation Tuesday: operator AST SpaceMobile announced the record-breaking spacecraft, whimsically called BlueBird 6, has ...

THE prehistoric “super carnivore” megalodon was bigger than previously thought, growing to a whopping 80ft and weighing 94 tons. The beast would have been four times bigger than the largest great ...

Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission. Major institutions are defined as firms or individuals that exercise ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Saudi Aramco leads as the world's top energy company with a $1.67 trillion market cap. ExxonMobil ranks as the largest U.S. oil firm, focusing on oil, gas, and low-emission solutions. Chevron utilizes ...

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close. Explore the world of large-cap stocks and learn how these can shape your portfolio.

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...